Emerging company roundup: Passage, IFM, Grey Wolf, Culture

In a week that had a pair of innovative Chinese companies raise early venture rounds and a Bay Area company debut its digital biomanufacturing platform, the biggest series A round went to Philadelphia gene therapy company Passage Bio Inc.

OrbiMed Advisors led a $115.5 million series A round for Passage Bio, which debuted Thursday to develop gene therapies to treat

Read the full 597 word article

User Sign In